165 related articles for article (PubMed ID: 25372834)
21. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
22. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
23. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
Staudt MR; Dittmer DP
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
[TBL] [Abstract][Full Text] [Related]
24. A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.
Hellert J; Weidner-Glunde M; Krausze J; Richter U; Adler H; Fedorov R; Pietrek M; Rückert J; Ritter C; Schulz TF; Lührs T
PLoS Pathog; 2013; 9(10):e1003640. PubMed ID: 24146614
[TBL] [Abstract][Full Text] [Related]
25. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.
Sun R; Liang D; Gao Y; Lan K
J Virol; 2014 Jul; 88(13):7331-44. PubMed ID: 24741090
[TBL] [Abstract][Full Text] [Related]
27. The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains.
Matsumura S; Persson LM; Wong L; Wilson AC
J Virol; 2010 Mar; 84(5):2318-30. PubMed ID: 20032179
[TBL] [Abstract][Full Text] [Related]
28. Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA.
Messick TE; Tolvinski L; Zartler ER; Moberg A; Frostell Å; Smith GR; Reitz AB; Lieberman PM
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290261
[TBL] [Abstract][Full Text] [Related]
29. Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes.
Beauchemin C; Moerke NJ; Faloon P; Kaye KM
J Biomol Screen; 2014 Jul; 19(6):947-58. PubMed ID: 24518064
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.
Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES
J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433
[TBL] [Abstract][Full Text] [Related]
31. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.
Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF
J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345
[TBL] [Abstract][Full Text] [Related]
32. Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.
Kaul R; Verma SC; Robertson ES
Virology; 2007 Aug; 364(2):317-29. PubMed ID: 17434559
[TBL] [Abstract][Full Text] [Related]
33. MLL1 is regulated by KSHV LANA and is important for virus latency.
Tan M; Li S; Juillard F; Chitas R; Custódio TF; Xue H; Szymula A; Sun Q; Liu B; Álvarez ÁL; Chen S; Huang J; Simas JP; McVey CE; Kaye KM
Nucleic Acids Res; 2021 Dec; 49(22):12895-12911. PubMed ID: 34850113
[TBL] [Abstract][Full Text] [Related]
34. LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex.
Hu J; Yang Y; Turner PC; Jain V; McIntyre LM; Renne R
PLoS Pathog; 2014 Jul; 10(7):e1004240. PubMed ID: 25033463
[TBL] [Abstract][Full Text] [Related]
35. Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus.
Hu J; Liu E; Renne R
J Virol; 2009 Nov; 83(21):11051-63. PubMed ID: 19710137
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
37. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus.
Cotter MA; Subramanian C; Robertson ES
Virology; 2001 Dec; 291(2):241-59. PubMed ID: 11878894
[TBL] [Abstract][Full Text] [Related]
38. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores.
Xiao B; Verma SC; Cai Q; Kaul R; Lu J; Saha A; Robertson ES
J Virol; 2010 Oct; 84(19):9718-32. PubMed ID: 20660191
[TBL] [Abstract][Full Text] [Related]
39. Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infections.
Kirsch P; Stein SC; Berwanger A; Rinkes J; Jakob V; Schulz TF; Empting M
Eur J Med Chem; 2020 Sep; 202():112525. PubMed ID: 32634628
[TBL] [Abstract][Full Text] [Related]
40. The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner.
Verma SC; Choudhuri T; Robertson ES
J Virol; 2007 Apr; 81(7):3402-13. PubMed ID: 17151118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
